Clasado Biosciences secures 11 health claims for GOS prebiotic in Colombia

Clasado Biosciences, a developer of gut microbiome product solutions, has received 11 self-substantiated health claims for its prebiotic galactooligosaccharide (GOS) ingredient, Bimuno GOS, in Colombia. The company says the ingredient’s health benefits claims are backed by rigorous scientific evidence. 

The company touts its ingredient’s prebiotic effect and role in supporting gastrointestinal health and immunity. It hails Bimuno GOS as the most widely studied prebiotic ingredient in the GOS category.

Across various international markets, Bimuno GOS has access to over 80 health claims.

“These health claims represent an important milestone for formulators in Colombia seeking to develop science-backed gut health products to meet rapidly growing consumer demand,” says Andrés Cárdenas, country manager at CTC Group.

“The combination of Bimuno GOS’s proven efficacy and clear regulatory status creates fantastic opportunities for brands to connect with health-conscious Colombian consumers, who increasingly understand the importance of supporting their gut microbiome.”

Enabling lower doses 

Bimuno GOS has a patented and unique proprietary structure that supports health benefits from a low dose.

The scientific supporting evidence for the ingredient includes over 120 publications and more than 20 clinical trials.

The latest positive regulatory outcome builds on the verification of the ingredient’s various health claims in markets around the globe, including the US, Canada, Asia, and Australia.

“Compliance with regulatory standards is paramount in the health and nutrition sector. In short, we’re engaging with a highly proactive market, and health consumers throughout Latin America want to know that there’s robust research and evidence behind the products they buy,” says Lucie Nagy, general counsel at Clasado.

“These health claims not only reinforce the scientific foundation of Bimuno GOS but also add substantial value for product formulators in Colombia. This achievement is a testament to our exceptional regulatory team’s hard work and dedication.”

Gut science advances

In other notable advances for gut science, a team of US-based researchers recently leveraged supercomputers to map the unique microorganisms populating the digestive system. Using this technology, the team is creating personalized diets to improve and optimize overall health.

Last month, Biohm Technologies, specializing in microbiome research, ingredients, and product solutions, upgraded its microbiome test kit solution with the Longevity Gut Report functionality. The new feature uses AI and bioinformatics to provide deeper insights into how an individual’s gut microbiome may influence the aging process.

Meanwhile, Nimble Science is upgrading healthcare services with its SIMBA Capsule, which collects and preserves precise samples directly from the small intestine when swallowed to advance personalized microbiome research.